Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans
CA 1339798 C · Owner: Cordon-Cardo, Carlos · Inventors: Fliegel, Bettina L.; Carswell, Elizabeth; Oettgen, Herbert F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a use of monoclonal antibody R-24 linked to a chemotherapeutic agent for the treatment of cancer of neuroectodermal origin, epithelial cancer of pigmentation disorder and wherein the chemotherapeutic agent is at least one agent from the group dacarbazine, adriamycin, pimozide dibromodulcitol, bleomycin, actinomycin D purine analog, pyrimidine analog, nitrosoureas cis-platin, radiation-emitting reagent tumor, necrosis factor, interferon, lymphotoxins interleukin, BCG, and, autologous tumor cell vaccine.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 7, 1998. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 7, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.